Also found in: Medical.
TexCAPSTexas Coronary Atherosclerosis Prevention Study
References in periodicals archive ?
Another new analysis of AFCAPS I TexCAPS data presented at the meeting demonstrated that lovastatin therapy for primary prevention significantly reduced the incidence of invasive cardiac procedures.
Nearly all of the clinical benefit in terms of reduced event rates in AFCAPS / TexCAPS occurred in patients in the lowest third of HDL distribution at baseline, those with an HDL below 34 mg/dL.